Nausea and vomiting in pregnancy and hyperemesis gravidarum Flashcards
When does nausea and vomiting normally start in pregnancy
Symptoms usually start from 4 – 7 weeks, are worst around 10 – 12 weeks and resolve by 16 – 20 weeks
What causes physiological N+V in pregnancy?
HCG produced by the placenta (Thought to protect against infection in pregnancy)
What are some conditions that increase severity of N+V in pregnancy
Molar pregnancy
Multiple pregnancy
First pregnancy
Obesity
What percentage of women get N+V in pregnancy
90%
What is hyperemesis gravidarum
the severe form of nausea and vomiting in pregnancy
What are the criteria for diagnosing hyperemesis gravidarum
- More than 5 % weight loss compared with before pregnancy
- Dehydration
- Electrolyte imbalance
- Ketosis
- Altered liver function
- Signs of malnutrition
- Emotional instability
- Wernicke’s encephalitis
What scoring system is used for N+V in pregnancy
PUQE score - Pregnancy-Unique Quantification of Emesis
PUQE score <7 =
Mild
PUQE score 7-12 =
Moderate
PUQE score 12-15
Severe
What is a possible genetic cause of severe N+V in pregnancy
Hypersensitivity to vomiting hormone growth differentiation factor 15 (GDF-15)
What are some symptoms of hypersensitivity to GDF-15
Loss of appetite
Taste aversion
Nausea + Vomiting
Weight loss
Peak at 20 weeks
Management of mild N+V in pregnancy
Oral anti-emetics at gome
Anti-emetic options for N+V in pregnancy
- Prochlorperazine (stemetil)
- Cyclizine
- Ondansetron
- Metoclopramide
When should admission be considered in mild N+V in pregnancy
- Unable to tolerate oral antiemetics or keep down any fluids
- More than 5 % weight loss compared with pre-pregnancy
- Ketonesare present in the urine on a urine dipstick (2 + ketones on the urine dipstick is significant)
- Other medical conditions need treating that required admission
Management of moderate-severe N+V in pregnancy
Ambulatory cate (Early pregnancy assessment unit)
Admission for:
- IV or IM antiemetics
- IV fluids (normal saline with added potassium chloride)
- Daily monitoring of U&Es while having IV therapy
- Thiamine supplementationto prevent deficiency (preventsWernicke-Korsakoff syndrome)
- Thromboprophylaxis(TED stockingandlow molecular weight heparin) during admission